This is a preview of subscription content, log in via an institution to check access.
Notes
National Health Insurance
Reference
Chugai Pharmaceutical Co Ltd. Anti-Cancer Agent, Antibody Drug Conjugate 'Kadcyla(Rm)': Postponement of Price Listing on the NHI Reimbursement List and Implementation of a New Clinical Study. Media Release : 13 Nov 2013. Available from: URL: http://www.chugai-pharma.co.jp
Rights and permissions
About this article
Cite this article
Trastuzumab emtansine: price listing in Japan delayed. PharmacoEcon Outcomes News 692, 11 (2013). https://doi.org/10.1007/s40274-013-0903-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0903-7